Crohn Disease Clinical Trials

Some trials specifically enroll patients in remission to study maintenance strategies or to compare long-term outcomes between treatments. However, most trials for new therapies require that you have active disease, typically confirmed by endoscopy and elevated inflammatory markers. Your current disease status determines which trials are appropriate.

Most treatment trials for active Crohn disease require a recent colonoscopy or ileocolonoscopy to confirm inflammation and establish a baseline endoscopic score. This is typically performed within four to six weeks before enrollment. Some trials accept flexible sigmoidoscopy or capsule endoscopy depending on your disease location.

Yes. Pediatric Crohn disease trials exist, though they are fewer in number than adult trials. These trials have additional safety protections and ethical oversight specific to minors. Pediatric gastroenterology centers at academic hospitals are the best resource for finding trials open to younger patients.

Trial protocols have predefined plans for managing flares, which may include corticosteroid rescue therapy or dose adjustments. If the study treatment is not controlling your disease after a defined period, the protocol will typically allow you to exit the trial and return to standard care. Your safety and disease management remain the priority.

Several rigorous clinical trials are studying specific dietary interventions, including the Crohn Disease Exclusion Diet (CDED) and variations of exclusive enteral nutrition. These trials use standardized protocols and objective endpoints like endoscopic healing. While results are promising, dietary approaches are being studied as complements to, not replacements for, medical therapy.